Literature DB >> 16495080

Bacterial fermentation of recombinant major wasp allergen Antigen 5 using oxygen limiting growth conditions improves yield and quality of inclusion bodies.

Stefanie Kischnick1, Bernhard Weber, Petra Verdino, Walter Keller, Ernst A Sanders, F Birger Anspach, Helmut Fiebig, Oliver Cromwell, Roland Suck.   

Abstract

A process for bacterial expression and purification of the recombinant major wasp allergen Antigen 5 (Ves v 5) was developed to produce protein for diagnostic and therapeutic applications for type 1 allergic diseases. Special attention was focused on medium selection, fermentation conditions, and efficient refolding procedures. A soy based medium was used for fermentation to avoid peptone from animal origin. Animal-derived peptone required the use of isopropyl-beta-D-thiogalactopyranoside (IPTG) for the induction of expression. In the case of soy peptone, a constitutive expression was observed, suggesting the presence of a component that mimics IPTG. Batch cultivation at reduced stirrer speed caused a reduced biomass due to oxygen limitation. However, subsequent purification and processing of inclusion bodies yielded significantly higher amount of product. Furthermore, the protein composition of the inclusion bodies differed. Inclusion bodies were denatured and subjected to diafiltration. Detailed monitoring of diafiltration enabled the determination of the transition point. Final purification was conducted using cation-exchange and size-exclusion chromatography. Purified recombinant Ves v 5 was analyzed by RP-HPLC, CD-spectroscopy, SDS-PAGE, and quantification ELISA. Up to 15 mg highly purified Ves v 5 per litre bioreactor volume were obtained, with endotoxin concentrations less than 20 EU mg(-1) protein and high comparability to the natural counterpart. Analytical results confirm the suitability of the recombinant protein for diagnostic and clinical applications. The results clearly demonstrate that not only biomass, but especially growth conditions play a key role in the production of recombinant Ves v 5. This has an influence on inclusion body formation, which in turn influences the renaturation rate and absolute product yield. This might also be true for other recombinant proteins that accumulate as inclusion bodies in Escherichia coli.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16495080     DOI: 10.1016/j.pep.2006.01.009

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  8 in total

1.  Recombinant phospholipase A1 (Ves v 1) from yellow jacket venom for improved diagnosis of hymenoptera venom hypersensitivity.

Authors:  Henning Seismann; Simon Blank; Liliana Cifuentes; Ingke Braren; Reinhard Bredehorst; Thomas Grunwald; Markus Ollert; Edzard Spillner
Journal:  Clin Mol Allergy       Date:  2010-04-01

Review 2.  How to achieve high-level expression of microbial enzymes: strategies and perspectives.

Authors:  Long Liu; Haiquan Yang; Hyun-dong Shin; Rachel R Chen; Jianghua Li; Guocheng Du; Jian Chen
Journal:  Bioengineered       Date:  2013-04-25       Impact factor: 3.269

3.  Display of wasp venom allergens on the cell surface of Saccharomyces cerevisiae.

Authors:  Irina Borodina; Bettina M Jensen; Ib Søndergaard; Lars K Poulsen
Journal:  Microb Cell Fact       Date:  2010-09-24       Impact factor: 5.328

4.  Comparison of two codon optimization strategies to enhance recombinant protein production in Escherichia coli.

Authors:  Hugo G Menzella
Journal:  Microb Cell Fact       Date:  2011-03-03       Impact factor: 5.328

5.  Heterologous Expression, Purification and Immunoreactivity of the Antigen 5 from Polybia paulista Wasp Venom.

Authors:  Murilo Luiz Bazon; Amilcar Perez-Riverol; José Roberto Aparecido Dos Santos-Pinto; Luis Gustavo Romani Fernandes; Alexis Musacchio Lasa; Débora Laís Justo-Jacomini; Mario Sergio Palma; Ricardo de Lima Zollner; Márcia Regina Brochetto-Braga
Journal:  Toxins (Basel)       Date:  2017-08-24       Impact factor: 4.546

6.  Custom made inclusion bodies: impact of classical process parameters and physiological parameters on inclusion body quality attributes.

Authors:  Christoph Slouka; Julian Kopp; Stefan Hutwimmer; Michael Strahammer; Daniel Strohmer; Elisabeth Eitenberger; Andreas Schwaighofer; Christoph Herwig
Journal:  Microb Cell Fact       Date:  2018-09-20       Impact factor: 5.328

Review 7.  Current Advances in Immunological Studies on the Vespidae Venom Antigen 5: Therapeutic and Prophylaxis to Hypersensitivity Responses.

Authors:  Murilo Luiz Bazon; Lais Helena Silveira; Patricia Ucelli Simioni; Márcia Regina Brochetto-Braga
Journal:  Toxins (Basel)       Date:  2018-07-24       Impact factor: 4.546

Review 8.  Wanted: more monitoring and control during inclusion body processing.

Authors:  Diana Humer; Oliver Spadiut
Journal:  World J Microbiol Biotechnol       Date:  2018-10-19       Impact factor: 3.312

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.